Alpha Teknova, Inc. (TKNO) stock
TKNONasdaqIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 12/30150% above fair value
$8.29−0.32 (-3.77%)
Close on Nov 12, 2026Market cap $445.34MP/E –Yield –
Alpha Teknova cash
Cash and short-term investments held at the end of each period.
Alpha Teknova's cash was $16.56M at Sep 30, 2026. For fiscal 2025 it was $21.34M, down 29.8% from the year before. The highest annual figure on record is $87.52M in fiscal 2021.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $21.34M | -29.8% |
| FY2024 | Dec 31, 2024 | $30.40M | +6.7% |
| FY2023 | Dec 31, 2023 | $28.48M | -32.6% |
| FY2022 | Dec 31, 2022 | $42.24M | -51.7% |
| FY2021 | Dec 31, 2021 | $87.52M | +1607.3% |
| FY2020 | Dec 31, 2020 | $5.13M | +23.7% |
| FY2019 | Dec 31, 2019 | $4.14M | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $16.56M | -25.1% |
| Q2 FY2026 | Jun 30, 2026 | $17.44M | -27.3% |
| Q1 FY2026 | Mar 31, 2026 | $17.78M | -32.3% |
| Q4 FY2025 | Dec 31, 2025 | $21.34M | -29.8% |
| Q3 FY2025 | Sep 30, 2025 | $22.12M | -30.2% |
| Q2 FY2025 | Jun 30, 2025 | $24.00M | +29.1% |
| Q1 FY2025 | Mar 31, 2025 | $26.27M | +21.7% |
| Q4 FY2024 | Dec 31, 2024 | $30.40M | +6.7% |
| Q3 FY2024 | Sep 30, 2024 | $31.69M | -1.3% |
| Q2 FY2024 | Jun 30, 2024 | $18.60M | -22.0% |
| Q1 FY2024 | Mar 31, 2024 | $21.60M | -28.5% |
| Q4 FY2023 | Dec 31, 2023 | $28.48M | -32.6% |
| Q3 FY2023 | Sep 30, 2023 | $32.11M | -35.6% |
| Q2 FY2023 | Jun 30, 2023 | $23.84M | -63.2% |
| Q1 FY2023 | Mar 31, 2023 | $30.22M | -60.5% |
| Q4 FY2022 | Dec 31, 2022 | $42.24M | -51.7% |
| Q3 FY2022 | Sep 30, 2022 | $49.86M | -49.1% |
| Q2 FY2022 | Jun 30, 2022 | $64.73M | -40.1% |
| Q1 FY2022 | Mar 31, 2022 | $76.46M | +428.5% |
| Q4 FY2021 | Dec 31, 2021 | $87.52M | +1607.3% |
| Q3 FY2021 | Sep 30, 2021 | $98.01M | +2669.5% |
| Q2 FY2021 | Jun 30, 2021 | $108.02M | +1465.5% |
| Q1 FY2021 | Mar 31, 2021 | $14.47M | +249.1% |
| Q4 FY2020 | Dec 31, 2020 | $5.13M | – |
| Q3 FY2020 | Sep 30, 2020 | $3.54M | – |
| Q2 FY2020 | Jun 30, 2020 | $6.90M | – |
| Q4 FY2019 | Dec 31, 2019 | $4.14M | – |
See a number that looks wrong?